The Latest SPAC News and Rumors: February 9, 2023

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Ocean Biomedical awarded new patents for antibodies that suppress multiple cancer types and Bite transfers listing to NYSE American

Ocean Biomedical and Aesther Healthcare Announce the Award of New Patents for Novel Monospecific and Bispecific Antibodies that Suppress Multiple Cancer Types

Ocean Biomedical and Aesther Healthcare Acquisition Corp. (NASDAQ: AEHA) announced today that Scientific Co-founder Dr. Jack A. Elias has been awarded multiple patents for his discoveries related to suppressing tumors by regulating CHI3L1 and several connected pathways.

Dr. Elias, the former Chair of Yale’s Department of Medicine, and the Dean Emeritus of Medicine and Biological Sciences at Brown University, has been granted Methods and Compositions patents for mono-specific and bi-specific antibody approaches for use in multiple cancer types.

Ocean Biomedical is expected to become a publicly traded company on the NASDAQ global market under the symbols “OCEA” and “OCEAW” following the closing of a Business Combination with Aesther Corporation.

Bite Acquisition Corp. Announces Transfer to NYSE American

Bite Acquisition Corp. (NYSE: BITE) announced today that it will transfer the listing of its common stock, units and warrants from the New York Stock Exchange to NYSE American LLC.

The Company anticipates its common stock, units and warrants will begin trading on NYSE American on Monday, February 13, 2023 under its current ticker symbols of BITE, BITE.U and BITE WS. The Company’s common stock, units and warrants have been approved for listing on NYSE American, and will continue to trade under the same ticker symbols on the New York Stock Exchange until the transfer is complete.